These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 1812300

  • 1. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Kawamura I, Mizota T, Kondo N, Shimomura K, Kohsaka M.
    Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
    [Abstract] [Full Text] [Related]

  • 2. Binding sites of droloxifene in the cytosol of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.
    Kawamura I, Lacey E, Tanaka Y, Nishigaki F, Manda T, Shimomura K.
    Jpn J Cancer Res; 1994 Jun; 85(6):639-44. PubMed ID: 8063618
    [Abstract] [Full Text] [Related]

  • 3. The estrogenic and antiestrogenic activities of droloxifene in human breast cancers.
    Kawamura I, Mizota T, Lacey E, Tanaka Y, Manda T, Shimomura K, Kohsaka M.
    Jpn J Pharmacol; 1993 Sep; 63(1):27-34. PubMed ID: 8271528
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
    Li S, Lévesque C, Geng CS, Yan X, Labrie F.
    Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
    [Abstract] [Full Text] [Related]

  • 5. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA, Asselin J, Caron MG, Labrie F, Raynaud JP.
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [Abstract] [Full Text] [Related]

  • 6. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL, Katzenellenbogen BS.
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [Abstract] [Full Text] [Related]

  • 7. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
    Heidemann PH, Wittliff JL, Calhoon RE, Boylan ES.
    J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
    [Abstract] [Full Text] [Related]

  • 8. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
    Wei LL, Mangel WF, Katzenellenbogen BS.
    J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.
    Nishino Y, Schneider MR, Michna H.
    J Cancer Res Clin Oncol; 1994 Dec; 120(5):298-302. PubMed ID: 8126059
    [Abstract] [Full Text] [Related]

  • 11. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
    Tominaga T, Yoshida Y, Kitamura M, Kosaki G.
    Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma.
    Kawamura I, Mizota T, Mukumoto S, Manda T, Masuda K, Nakamura T, Kubota H, Matsumoto S, Nishigaki F, Shimomura K.
    Arzneimittelforschung; 1989 Aug; 39(8):889-93. PubMed ID: 2818677
    [Abstract] [Full Text] [Related]

  • 14. TAT-59, a new triphenylethylene derivative with antitumor activity against hormone-dependent tumors.
    Toko T, Sugimoto Y, Matsuo K, Yamasaki R, Takeda S, Wierzba K, Asao T, Yamada Y.
    Eur J Cancer; 1990 Mar; 26(3):397-404. PubMed ID: 2141500
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen.
    Mansour A, Daba A, Baddour N, El-Saadani M, Aleem E.
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1579-96. PubMed ID: 22552717
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen.
    Shigaki N, Kimura M, Takano S, Fujino N, Akagi M.
    Jpn J Surg; 1987 Sep; 17(5):395-401. PubMed ID: 3123757
    [Abstract] [Full Text] [Related]

  • 19. Beta-adrenergic receptors in DMBA-induced rat mammary tumors: correlation with progesterone receptor and tumor growth.
    Marchetti B, Spinola PG, Plante M, Poyet P, Folléa N, Pelletier G, Labrie F.
    Breast Cancer Res Treat; 1989 Jul; 13(3):251-63. PubMed ID: 2569332
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.